# Onco'Zine: International Oncology Network \- Cancer \& Hematology News > Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs. ## Pages - [Sunvalley Communication](https://www.oncozine.com/sunvalley-communication/) - [Artificial Intelligence \(AI\) and Risk Assessment in Metastatic Hormone\-Sensitive Prostate Cancer\.](https://www.oncozine.com/artificial-intelligence-ai-and-risk-assessment-in-metastatic-hormone-sensitive-prostate-cancer/) - [About Onco'Zine](https://www.oncozine.com/about-oncozine/about-oncozine-2/) - [Schedule a Meeting](https://www.oncozine.com/schedule-a-meeting/) - [Home](https://www.oncozine.com/) ## Posts - [Mike Caligiuri Discusses Upcoming AACR Meeting, Cancer Health Equality, and Sudden Career Change](https://www.oncozine.com/mike-caligiuri-discusses-upcoming-aacr-meeting-cancer-health-equality-and-his-sudden-career-change/) - [Oncoceutics Extends Patent Family to Include ONC201 In Leukemias](https://www.oncozine.com/oncoceutics-extends-patent-family-include-onc201/) - [RiskScore Demonstrates Highly Statistically\-Significant Ability](https://www.oncozine.com/riskscore-demonstrates-highly-statistically-significant-ability-predict-5-year-lifetime-risk-breast-cancer/) - [From Cold to Responsive: What Recent Clinical Advances Tell Us About Tumor Priming and Checkpoint Blockade](https://www.oncozine.com/from-cold-to-responsive-what-recent-clinical-advances-tell-us-about-tumor-priming-and-checkpoint-blockade/): Checkpoint inhibitors can only amplify an antitumor immune response that already exists, which is why immunologically “cold” tumors remain one of immuno\-oncology’s most persistent challenges\. Drawing on the recent U/S\. Food and Drug Administration's approval of vusolimogene oderparepvec\-wtpg \(Tudriqev™, formerly known as RP1; Replimune\), the intismeran autogene results, a negative BioNTech colorectal trial, and new preclinical data on GeoVax’s Gedeptin®, David A\. Dodd, Chairman, President and Chief Executive Officer of GeoVax Labs, and Kelly T\. McKee, Jr\., MD, MPH is Chief Medical Officer at GeoVax, argue that the next advances may come from pairing checkpoint blockade with therapies that first generate or strengthen the immune response worth unleashing\. - [Engineering Salmonella Against Triple\-Negative Breast Cancer: UMass Amherst Awarded $13\.1 Million](https://www.oncozine.com/engineering-salmonella-against-triple-negative-breast-cancer-umass-amherst-awarded-13-1-million/): Engineered bacteria are moving from curiosity to a funded platform\. A five\-year, $13\.1 million National Institutes of Health \(NIH\) award to the University of Massachusetts Amherst will build nontoxic Salmonella strains that deliver three distinct therapies into drug\-resistant triple\-negative breast tumors\. The work is preclinical, but the published groundwork is specific enough to warrant medical oncologists' attention\. ## Job Openings - [Advertisement and Sponsorship Sales Representative](https://www.oncozine.com/jobs/advertisement-and-sponsorship-sales-representative/) ## Lists - [Official Merchandise](https://www.oncozine.com/ctct_lists/official-merchandise/) - [Java Original Coffee \- Wholesale](https://www.oncozine.com/ctct_lists/java-original-coffee-wholesale/) - [Java Coffee Academy Wait List 2027](https://www.oncozine.com/ctct_lists/java-coffee-academy-wait-list-2027/) - [CDMO UK](https://www.oncozine.com/ctct_lists/cdmo-uk/) - [ADC Review Manuscript Submission](https://www.oncozine.com/ctct_lists/adc-review-manuscript-submission/) ## Categories - [News](https://www.oncozine.com/category/news/) - [Conference Coverage](https://www.oncozine.com/category/conference-coverage/) - [Research \& Development](https://www.oncozine.com/category/research-and-development/) - [Clinical development](https://www.oncozine.com/category/clinical-development/) - [Cancer Risk](https://www.oncozine.com/category/cancer-risk/) ## Tags - [breast cancer](https://www.oncozine.com/tag/breast-cancer/) - [Cancer](https://www.oncozine.com/tag/cancer/) - [ASCO](https://www.oncozine.com/tag/asco/) - [ADC](https://www.oncozine.com/tag/adc/) - [lung cancer](https://www.oncozine.com/tag/lung-cancer/) ## Job Type - [Subcontractor](https://www.oncozine.com/job-type/subcontractor/) - [Commission](https://www.oncozine.com/job-type/commission/) ## Optional - [Sitemap index](https://www.oncozine.com/sitemap_index.xml)